ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 274,09
-0,97%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Better Therapeutics Inc (BTTX)

  7. Better Therapeutics Inc (BTTX) Actualités

BTTX

Better Therapeutics (BTTX)

Better Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BTTX
DateHeureSourceTitreSymboleSociété
14/03/202414h38Business WireBetter Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from NasdaqNASDAQ:BTTXBetter Therapeutics Inc
11/03/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
05/03/202415h25Business WireBetter Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health CentersNASDAQ:BTTXBetter Therapeutics Inc
04/03/202415h25Business WireBetter Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)NASDAQ:BTTXBetter Therapeutics Inc
01/03/202412h08Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BTTXBetter Therapeutics Inc
20/02/202415h25Business WireBetter Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver DiseaseNASDAQ:BTTXBetter Therapeutics Inc
12/02/202422h28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
06/02/202415h43Business WireBetter Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes TreatmentNASDAQ:BTTXBetter Therapeutics Inc
06/02/202415h02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
23/01/202423h22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BTTXBetter Therapeutics Inc
17/01/202415h28Business WireBetter Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care AloneNASDAQ:BTTXBetter Therapeutics Inc
10/01/202413h01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BTTXBetter Therapeutics Inc
04/01/202420h00Business WireBetter Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United StatesNASDAQ:BTTXBetter Therapeutics Inc
02/01/202413h45Business WireBetter Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver DiseaseNASDAQ:BTTXBetter Therapeutics Inc
28/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BTTXBetter Therapeutics Inc
20/12/202323h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
13/12/202323h24Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BTTXBetter Therapeutics Inc
08/12/202302h09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
28/11/202313h45Business WireBetter Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost ReductionsNASDAQ:BTTXBetter Therapeutics Inc
14/11/202313h00Business WireFrost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership AwardNASDAQ:BTTXBetter Therapeutics Inc
09/11/202313h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BTTXBetter Therapeutics Inc
09/11/202313h00Business WireBetter Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:BTTXBetter Therapeutics Inc
08/11/202313h30Business WireBetter Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023NASDAQ:BTTXBetter Therapeutics Inc
26/10/202313h55Business WireBetter Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual ConferenceNASDAQ:BTTXBetter Therapeutics Inc
16/10/202313h55Business WireBetter Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 DiabetesNASDAQ:BTTXBetter Therapeutics Inc
16/10/202313h22Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BTTXBetter Therapeutics Inc
12/10/202322h17Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
11/10/202313h55Business WireBetter Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 DiabetesNASDAQ:BTTXBetter Therapeutics Inc
06/10/202322h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BTTXBetter Therapeutics Inc
05/10/202313h45Business WireBetter Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep AdvancesNASDAQ:BTTXBetter Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BTTX

Dernières Valeurs Consultées

NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
EU
PX4
SBF 120
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
EU
VIV
Vivendi
EU
ACA
Credit Agricole
EU
BEL20
Bel 20
EU
ML
Michelin
EU
AF
Air FranceKLM
EU
SGO
Cie de SaintGobain
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés